Hopkins tests common supplement to calm harmful behaviors in rare genetic disorder
NCT ID NCT04381897
Summary
This small pilot study aims to see if the supplement N-acetylcysteine (NAC) can help reduce repetitive and self-injurious behaviors in teens and adults with Cornelia de Lange Syndrome (CdLS). Ten participants will take either NAC or a placebo for 8-week periods to compare effects. The goal is to ease these challenging behaviors to improve daily life for individuals and their families.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNELIA DE LANGE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.